GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 711 filers reported holding GLAXOSMITHKLINE PLC in Q3 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $823,000 | +201.5% | 18,900 | +204.8% | 0.01% | +400.0% |
Q4 2021 | $273,000 | +27.6% | 6,200 | +9.1% | 0.00% | -50.0% |
Q3 2020 | $214,000 | -99.1% | 5,683 | -98.9% | 0.00% | -99.1% |
Q4 2019 | $23,419,000 | +19.9% | 498,389 | +8.9% | 0.43% | -20.8% |
Q3 2019 | $19,538,000 | +6.9% | 457,787 | +0.3% | 0.54% | +4.7% |
Q2 2019 | $18,275,000 | +8686.1% | 456,636 | +8264.8% | 0.51% | +6325.0% |
Q1 2019 | $208,000 | -1.4% | 5,459 | +4.3% | 0.01% | -38.5% |
Q2 2018 | $211,000 | -65.0% | 5,233 | -69.2% | 0.01% | -76.8% |
Q4 2017 | $603,000 | -53.6% | 16,996 | -43.6% | 0.06% | -55.6% |
Q2 2017 | $1,300,000 | +543.6% | 30,141 | +520.1% | 0.13% | +260.0% |
Q2 2015 | $202,000 | -21.4% | 4,861 | -12.9% | 0.04% | -2.8% |
Q3 2014 | $257,000 | -5.2% | 5,580 | +3.3% | 0.04% | -12.2% |
Q3 2013 | $271,000 | +11.1% | 5,404 | +10.8% | 0.04% | -8.9% |
Q2 2013 | $244,000 | – | 4,879 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |